Business
GPT Healthcare Limited (“the Company”) is engaged in the Healthcare Services i.e running of hospitals and providing medical services. We operate a chain of mid-sized full service hospitals under the brand name of “ILS Hospitals” and provide integrated healthcare services, with a focus on secondary and tertiary care. We presently operate five multispecialty hospitals in Dum Dum, Salt Lake and Howrah in West Bengal, Agartala in Tripura and Raipur in Chhattisgarh with a total capacity of 719 beds.
Annual General Meeting
2026
| Date of Annual General Meeting: | Thursday, August 6, 2026 at 3.00 P.M. (IST) through Video Conferencing and Other Audio-Visual Means (“VC/OAVM”) |
| Mode of Meeting (Place): | To be held through Video Conferencing (VC) Mode. |
| Book Closure: | The Register of Members and Share Transfer Books of the Company will remain closed from Friday July 31, 2026 to Thursday August 6, 2026 (both days inclusive). |
| Record (Cut Off) Date: | Thursday, July 30, 2026 |
| Remote e-Voting: | The remote e-voting period commences on Monday, August 3, 2026 (at 9.00 a.m. IST) and ends on Wednesday, August 5, 2026 (at 5.00 p.m. IST). |
| Particulars | Download |
|---|---|
| Voting Results and Scrutinizer Report on 37th Annual General Meeting |  |
| Proceedings of the 37th Annual General Meeting of the Company | |
| Notice of 37th Annual General Meeting of the Company | |
| Intimation regarding the 37th Annual General Meeting, Dividend & Book Closure and Record date | |
| Newspaper Publication of Pre Despatch of AGM Notice | |
| Newspaper Publication of Post Despatch of AGM Notice | |
2025
Date of Annual General Meeting: Tuesday, August 5, 2025 at 3.00 P.M. (IST) through Video Conferencing and Other Audio-Visual Means (“VC/OAVM”) Mode of Meeting (Place): To be held through Video Conferencing (VC) Mode. Book Closure: The Register of Members and Share Transfer Books of the Company will remain closed from Wednesday July 30, 2025 to Tuesday August 5, 2025 (both days inclusive) Record (Cut Off) Date: Tuesday, July 29, 2025 Remote e-Voting: The remote e-voting period commences on Saturday, August 2, 2025 (at 9.00 a.m. IST) and ends on Monday, August 4, 2025 (at 5.00 p.m. IST). Particulars Download Voting Results and Scrutinizer Report on 36th Annual General Meeting Outcome and Proceeding of the 36th Annual General Meeting of the Company. Notice of 36th Annual General Meeting of the Company Intimation regarding the 36th Annual General Meeting, Dividend & Book Closure and Record date Newspaper Publication of Pre Despatch of AGM Notice Newspaper Publication of Post Despatch of AGM Notice 2024
Date of Annual General Meeting: Thursday, July 25, 2024 at 3.00 P.M. (IST) through Video Conferencing and Other Audio-Visual Means (“VC/OAVM”) Mode of Meeting (Place): To be held through Video Conferencing (VC) Mode. Book Closure: The Register of Members and Share Transfer Books of the Company will remain closed from Friday, July 19, 2024 to Thursday, July 25, 2024 (both days inclusive) Record (Cut Off) Date: Thursday, July 18, 2024 Remote e-Voting: The remote e-voting period commences on Monday, July 22, 2024 (at 9.00 a.m. IST) and ends on Wednesday, July 24, 2024 (at 5.00 p.m. IST). Particulars Download Voting Results and Scrutinizer Report on 35th Annual General Meeting Proceedings of the 35th Annual General Meeting of the Company Notice of 35th Annual General Meeting of the Company Intimation regarding the 35th Annual General Meeting, Dividend & Book Closure and Record date Newspaper Publication of Pre Despatch of AGM Notice Newspaper Publication of Post Despatch of AGM Notice
Postal Ballot
2025
| Particulars | Download |
|---|---|
| Postal Ballot Notice | |
| News paper Notice for Postal Ballot and E-voting | |
| Scrutinizer Report | |
| Postal Ballot Result | |
2024
Particulars Download Postal Ballot Notice News paper Notice for Postal Ballot and E-voting Scrutinizer Report Postal Ballot Result
Shareholding Pattern
| Financial Year | Q 1 | Q 2 | Q 3 | Q 4 |
|---|---|---|---|---|
| 2026-2027 | | | NA | NA |
| 2025-2026 | | | | |
| 2024-2025 | | | | |
| 2023 - 2024 | NA | NA | NA | |
Share Capital
| Authorised Share Capital | Rs. 125,00,00,000 Divided into 12,50,00,000 Equity Shares of Rs. 10/- Each. |
| Issued, Paid-Up & Subscribed Capital | Rs. 82,05,48,230 Divided into 8,20,54,823 Equity Shares of Rs. 10/- Each. |
Integrated Filings
Integrated Filing (Financial)
| Financial Year | Q 1 | Q 2 | Q 3 | Q 4 |
|---|---|---|---|---|
| 2026-2027 | | | NA | NA |
| 2025-2026 | | | | |
| 2024-2025 | NA | NA | | |
Integrated Filing (Governance)
| Financial Year | Q 1 | Q 2 | Q 3 | Q 4 |
|---|---|---|---|---|
| 2026-2027 | | | NA | NA |
| 2025-2026 | | | | |
| 2024-2025 | NA | NA | | |
Earnings Call
| Quarter | Earnings Presentation | Call Invite | Earnings Call Transcript |
|---|---|---|---|
| Q2: 2026-27 | | | NA |
| Q1: 2026-27 | | |  |
| Q4: 2025-26 | | | |
| Q3: 2025-26 | | | |
| Q2: 2025-26 | | | |
| Q1: 2025-26 | | | |
| Q4: 2024-25 | | | |
| Q3: 2024-25 | | | |
| Q2: 2024-25 | | | |
| Q1: 2024-25 | | | |
| Q4: 2023-24 | | | |
| Q3: 2023-24 | | | |
| Q2: 2023-24 | NA | NA | NA |
| Q1: 2023-24 | NA | NA | NA |
Dividend
Details of Dividend declared and the respective due dates for transfer of the unclaimed/unpaid dividend to IEPF
| Dividend for the Financial Year | Date of declaration of Dividend | Type of Dividend | Amount of Dividend declared | Rate of dividend (%) | Due date of Transfer to IEPF | Remarks |
|---|---|---|---|---|---|---|
| 2026-27 | 05.11.2026 | Interim Dividend | 8,20,54,823 | 10% (Rs. 1.00 per share) | 11.12.2033 | |
| 2025-26 | 06.08.2026 | Final Dividend | 12,30,82,234.50 | 15% (Rs. 1.50 per share) | 11.09.2033 | - |
| 08.11.2025 | Interim Dividend | 8,20,54,823 | 10% (Rs. 1.00 per share) | 14.12.2032 | - | |
| 2024-25 | 14.11.2024 | Interim Dividend | 8,20,54,823 | 10% (Rs. 1.00 per share) | 20.12.2031 | - |
| 05.08.2025 | Final Dividend | 12,30,82,234.50 | 15% (Rs. 1.50 per share) | 10.09.2032 | - | |
| 2023-24 | 05.01.2024 | Interim Dividend | 7,99,04,286 | 10% (Rs. 1.00 per share) | 10.01.2031 | No Unpaid Dividend |
| 19.03.2024 | Interim Dividend | 8,20,54,823 | 10% (Rs. 1.00 per share) | 24.04.2031 | - | |
| 25.07.2024 | Final Dividend | 12,30,82,234.50 | 15% (Rs. 1.50 per share) | 30.08.2031 | - |
Unpaid Dividend
| List of Unpaid/Unclaimed Dividend as on March 31, 2026 | Download |
|---|---|
| Unpaid Dividend Details for 1st Interim Dividend For The Year 2025-2026 | |
| Unpaid Dividend Details for Final Dividend for the Year 2024-2025 | |
| Unpaid Dividend Details for 1st Interim Dividend For The Year 2024-2025 | |
| Unpaid Dividend Details for Final Dividend for the Year 2023-2024 | |
| Unpaid Dividend Details for 2nd Interim Dividend for the Year 2023-2024 | |
| List of Unpaid/Unclaimed Dividend as on March 31, 2025 | Download |
|---|---|
| Unpaid Dividend Details for 1st Interim Dividend For The Year 2024-2025 | |
| Unpaid Dividend Details for Final Dividend for the Year 2023-2024 | |
| Unpaid Dividend Details for 2nd Interim Dividend for the Year 2023-2024 | |
Corporate Presentation
| Particulars | Download |
|---|---|
| Corporate Presentation 2026 | |
| Corporate Presentation 2025 | |
| Corporate Presentation 2024 | |
Corporate Policies
| Policy Document | Download |
|---|---|
| GHL-Board Performance Appraisal Policy | |
| GHL-Code of Conduct for Board and Senior Mangers | |
| GHL-Code of Conduct for Prevention of Insider Trading | |
| GHL-Code of Corporate Disclosure for PIT | |
| GHL-Criteria for making payment to Non Executive Directors | |
| GHL-CSR Policy | |
| GHL-Diversity Policy | |
| GHL-Dividend Policy | |
| GHL-Familiarisation Programme for IDs | |
| GHL-Materiality Policy for Disclosure in Offer Documents | |
| GHL-Materiality Subsidiary Policy | |
| GHL-Nomination and Remuneration Policy | |
| GHL-Policy for Determining Materiality for Disclosure | |
| GHL-Policy for Document Retention and Archival | |
| GHL-Policy on Succession Planning | |
| GHL-Related Party Transactions Policy | |
| GHL-Risk Management Policy | |
| GHL-Sexual Harassment Policy | |
| GHL-Terms of Appointment of Independent Director | |
| GHL-Vigil Mechanism Policy | |
Compliances
Related Party Transactions
| Compliances Document | Link |
|---|---|
| Related Party Transactions | |
| Related Party Transactions |
Compliance under Regulation 74(5) of the SEBI (DP) Regulations, 2018
| Compliances Document | Download |
|---|---|
| Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for Q.E September 30, 2026 | |
| Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for Q.E June 30, 2026 | |
| Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for Q.E March 31, 2026 | |
| Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for Q.E December 31, 2025 | |
| Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for Q.E September 30, 2025 | |
| Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for Q.E June 30, 2025 | |
| Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for Q.E March 31, 2025 | |
| Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for Q.E December 31, 2024 | |
| Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for Q.E September 30, 2024 | |
| Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for Q.E June 30, 2024 | |
| Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for Q.E March 31, 2024 | |
Compliance under Reg. 13(3) of Listing Regulations
| Compliances Document | Download |
|---|---|
| Investor Compliant for the Q.E 31.12.2024 XBRL | |
| Investor Compliant for the Q.E 30.09.2024 XBRL | |
| Investor Compliant for the Q.E 30.06.2024 XBRL | |
| Investor Compliant for the Q.E 31.03.2024 XBRL | |
Reconciliation of Share Capital Audit
| Compliances Document | Download |
|---|---|
| Reconciliation of Share Capital Audit 30.09.2026 | |
| Reconciliation of Share Capital Audit 30.06.2026 | |
| Reconciliation of Share Capital Audit 31.03.2026 | |
| Reconciliation of Share Capital Audit 31.12.2025 | |
| Reconciliation of Share Capital Audit 30.09.2025 | |
| Reconciliation of Share Capital Audit 30.06.2025 | |
| Reconciliation of Share Capital Audit 31.03.2025 | |
| Reconciliation of Share Capital Audit 31.12.2024 | |
| Reconciliation of Share Capital Audit 30.09.2024 | |
| Reconciliation of Share Capital Audit 30.06.2024 | |
| Reconciliation of Share Capital Audit 31.03.2024 | |
Compliance under Reg. 32 of Listing Regulations
| Compliances Document | Download |
|---|---|
| Statement Of Deviation For The Quarter Ended March 31, 2024 | |
Compliance under Reg. 40(9) of Listing Regulations
| Compliances Document | Download |
|---|---|
| Certificate pursuant to Regulation 40(9) & (10) of the SEBI (LODR), Regulations, 2015 for the Q.E March 31, 2024 | |
Compliance under Reg. 7(3) of Listing Regulations
| Compliances Document | Download |
|---|---|
| Compliance Certificate under reg 7(3) of the SEBI (LODR) Regulations, 2015 for the year ended March 31, 2024. | |
Notices
| Type | Subject | Financial Year | Details | Download |
|---|---|---|---|---|
| Record Date | Record Date Notice for Dividend | 2026-27 | Interim Dividend for FY 2026-27 | |
| Board Meeting Notice | Intimation of Board Meeting to be held on November 5, 2026 | 2026-27 | Approval of Un-Audited FR for the Q2 and Half year ended September 30, 2026 | |
| Board Meeting Notice | Intimation of Board Meeting to be held on August 3, 2026 | 2026-27 | Approval of Un-Audited FR for the Q1 ended June 30, 2026 | |
| Board Meeting Notice | Intimation of Board Meeting to be held on May 18, 2026 | 2026-27 | Approval of Audited FR for the Q4 and Year ended March 31, 2026 | |
| AGM, Book Closure and Record Date | Details Related to AGM, Book Closure and Record Date | 2025-26 | Intimation regarding the 37th AGM, Dividend, Book Closure and Record date | |
| Board Meeting Notice | Intimation of Board Meeting to be held on February 2, 2026 | 2025-26 | Approval of Un-Audited FR for the Q3 ended December 31, 2025. | |
| Record Date | Record Date Notice for Dividend | 2025-26 | Interim Dividend for FY 2025-26 | |
| Board Meeting Notice | Intimation of Board Meeting to be held on November 8, 2025 | 2025-26 | Approval of Un-Audited FR for the Q2 and Half year ended September 30, 2025 | |
| Board Meeting Notice | Intimation of Board Meeting to be held on August 6, 2025 | 2025-26 | Approval of Un-Audited FR for the Q1 ended June 30, 2025. | |
| AGM, Book Closure and Record Date | Details Related to AGM, Book Closure and Record Date | 2024-25 | Intimation regarding the 36th AGM, Dividend, Book Closure and Record date | |
| Board Meeting Notice | Intimation of Board Meeting to be held on May 23, 2025 | 2025-26 | Approval of Audited FR for the Q4 and Year ended March 31, 2025 | |
| Board Meeting Notice | Intimation of Board Meeting to be held on February 11, 2025 | 2024-25 | Approval of Un-Audited FR for the Q3 ended December 31, 2024 | |
| Record Date | Record Date Notice for Dividend | 2024-25 | First Interim Dividend for FY 2024-25 | |
| Board Meeting Notice | Intimation of Board Meeting to be held on November 14, 2024 | 2024-25 | Approval of Un-Audited FR for the Q2 and Half year ended September 30, 2024 | |
| Board Meeting Notice | Intimation of Board Meeting to be held on August 13, 2024 | 2024-25 | Approval of Un-Audited FR for the Q1 ended June 30, 2024 | |
| Board Meeting Notice | Intimation of Board Meeting to be held on May 21, 2024 | 2024-25 | Approval of FR for the Q4 and Year ended March 31, 2024 | |
| AGM, Book Closure and Record Date | Details Related to AGM, Book Closure and Record Date | 2023-24 | Intimation regarding the 35th AGM, Dividend & Book Closure and Record date | |
| Board Meeting Notice | Intimation of Board Meeting to be held on March 19, 2024. | 2023-24 | Approval of UFR for the Q3 9M ended December 31, 2023 | |
| Record date | Record Date Notice for Dividend | 2023-24 | Second Interim Dividend | |
Disclosure Information
| Date | Document | Download |
|---|---|---|
| 05.11.2026 | Outcome of Board Meeting held on November 5, 2026 | |
| 05.11.2026 | Declaration of Interim Dividend and Notice of Record Date | |
| 05.11.2026 | Submission of Un-Audited Financial Results for the 2™ quarter and half year ended September 30, 2026 | |
| 05.11.2026 | Investor Presentation on Un-Audited Financial Results for the 2nd quarter and half year ended September 30, 2026 | |
| 05.11.2026 | Press Release on Un-Audited Financial Results for the 2nd quarter and half year ended September 30, 2026 | |
| 02.11.2026 | Intimation of Earnings Call to discuss the financial performance of the Company for the 2nd quarter and half year ended September 30, 2026 | |
| 27.10.2026 | Intimation of Board Meeting pursuant to Regulations 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on November 5, 2026. | |
| 27.10.2026 | Appointment of Cygnus Partners Private Limited for providing Investor Relations Advisory Services | |
| 08.10.2026 | Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for Q.E September 30, 2026 | |
| 28.09.2026 | Closure of Trading Window | |
| 21.09.2026 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 07.08.2026 | Transcript of the conference call on Un-Audited Financial Results for the 1st quarter ended on June 30, 2026 | |
| 07.08.2026 | Voting Results and Scrutinizer Report on 37th Annual General Meeting | |
| 06.08.2026 | Outcome and Proceeding of the 37th Annual General Meeting of the Company. | |
| 04.08.2026 | Newspaper Publication of Q1FY27 Financial Results | |
| 03.08.2026 | Press Release for the Q1 ended June 30, 2026. | |
| 03.08.2026 | Submission of Results for the Q1 ended June 30, 2026. | |
| 03.08.2026 | Outcome of Board Meeting held on August 3, 2026. | |
| 03.08.2026 | Submission of Investors Presentation Q1 FY2027. | |
| 25.07.2026 | Intimation of Earnings Call to discuss the financial performance of the Company for the 1st quarter ended June 30, 2026. | |
| 25.07.2026 | Intimation of Board Meeting pursuant to Regulations 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on August 3, 2026. | |
| 11.07.2026 | Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for Q.E June 30, 2026 | |
| 10.07.2026 | Newspaper Publication of Post Despatch of AGM Notice | |
| 09.07.2026 | Submission of Annual Report including Notice of 37th AGM | |
| 09.07.2026 | Submission of Notice of 37th Annual General Meeting on Thursday, August 6, 2026 | |
| 09.07.2026 | Dispatch of Letter under Reg 36(1)(b) | |
| 03.07.2026 | Newspaper Publication of Pre Despatch of AGM Notice | |
| 27.06.2026 | Closure of Trading Window | |
| 08.06.2026 | Intimation regarding Second 100 days campaign-"Saksham Niveshak". | |
| 05.06.2026 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 26.05.2026 | Secretarial Compliance Report for the year ended March 31, 2026 | |
| 23.05.2026 | Newspaper Publication of Second 100 Days Campaign-“Saksham Niveshak” | |
| 20.05.2026 | Newspaper Publication of Q4 FY26 Audited Financial Results | |
| 19.05.2026 | Audio Recording of Q4 & FY26 Earnings call held today i.e May 19, 2026. | |
| 18.05.2026 | Outcome of Board Meeting held on May 18, 2026 | |
| 18.05.2026 | Submission of Results for the Q4 and Year ended March 31, 2026 | |
| 18.05.2026 | Press Release for the Q4 and Year ended March 31, 2026 | |
| 18.05.2026 | Submission of Investors Presentation Q4 FY2026 | |
| 18.05.2026 | Details of 37th Annual General Meeting, Book Closure Date and Record Date for Dividend | |
| 11.05.2026 | Intimation of earnings call for discussion on Audited Financial Results for the 4th quarter and financial year ended March 31, 2026 | |
| 11.05.2026 | Intimation of Board Meeting pursuant to Regulations 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on May 18, 2026. | |
| 10.04.2026 | Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for Q.E March 31, 2026 | |
| 02.04.2026 | Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. | |
| 26.03.2026 | Closure of Trading Window | |
| 05.03.2026 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 02.03.2026 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 06.02.2026 | Update on Conference Call held on November 11, 2025 - Call Transcript | |
| 03.02.2026 | Audio Recording of Q3 & 9MFY26 Earnings call held today i.e February 3, 2026. | |
| 03.02.2026 | Newspaper Publication of Q3 & 9MFY26 Un-Audited Financial Results | |
| 02.02.2026 | Outcome of Board Meeting held on February 2, 2026 | |
| 02.02.2026 | Submission of Results for the Q3 ended December 31, 2025. | |
| 02.02.2026 | Press Release on UFR for the Q3 ended December 31, 2025. | |
| 02.02.2026 | Investor Presentation on Investor Presentation on Un-Audited Financial Results for the 3rd quarter and nine months ended December 31, 2025. | |
| 27.01.2026 | Intimation of Board Meeting pursuant to Regulations 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on February 2, 2026. | |
| 27.01.2026 | Intimation of Earnings Call to discuss the financial performance of the Company for the 3rd quarter and nine months (Q3 & 9MFY26) ended December 31, 2025 | |
| 06.01.2026 | Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for Q.E December 31, 2025 | |
| 29.12.2025 | Closure of Trading Window | |
| 26.12.2025 | Appointment of MUFG Intime India Private Ltd for providing Investor Relations Advisory Services | |
| 14.11.2025 | Update on Conference Call held on November 11, 2025 - Call Transcript | |
| 11.11.2025 | Audio Recording of Q2 & H1 FY2026 Earnings call held today i.e November 11, 2025 | |
| 10.11.2025 | Newspaper Publication of Q2 & H1 FY26 Un-Audited Financial Results | |
| 08.11.2025 | Declaration of Interim Dividend and Notice of Record Date | |
| 08.11.2025 | Submission of Un-Audited Financial Results for the 2™ quarter and half year ended September 30, 2025 | |
| 08.11.2025 | Outcome of Board Meeting held on November 8, 2025 | |
| 08.11.2025 | Investor Presentation on Un-Audited Financial Results for the 2nd quarter and half year ended September 30, 2025 | |
| 08.11.2025 | Press Release on Un-Audited Financial Results for the 2nd quarter and half year ended September 30, 2025 | |
| 04.11.2025 | Intimation of Earnings Call to discuss the financial performance of the Company for the 2nd quarter and half year ended September 30, 2025 | |
| 31.10.2025 | Intimation of Board Meeting pursuant to Regulations 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on November 8, 2025. | |
| 29.10.2025 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | |
| 29.10.2025 | Appointment (Regularization) of Mr. Shree Gopal Tantia, Promoter (DIN:00001346) as Non-Executive Director of the Company | |
| 29.10.2025 | Outcome of Postal Ballot and Submission of Scrutinizer Report and Voting Results of the Postal ballot of GPT Healthcare Limited | |
| 15.10.2025 | Publication of Notice in newspapers regarding 100 Days Campaign - “Saksham Niveshak” | |
| 14.10.2025 | Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for Q.E September 30, 2025 | |
| 27.09.2025 | Closure of Trading Window | |
| 27.09.2025 | Newspaper Publication of Notice of Postal Ballot | |
| 26.09.2025 | Postal Ballot Notice- Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. | |
| 26.09.2025 | Intimation Regarding 100 Days Campaign-'Saksham Niveshak' | |
| 24.09.2025 | Change in Directorate | |
| 24.09.2025 | Outcome of Board Meeting held on September 24,2025 | |
| 09.09.2025 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 30.08.2025 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 18.08.2025 | Intimation of sad demise of Shri Dwarika Prasad Tantia, Executive Chairman and Promoter of the Company under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | |
| 18.08.2025 | Press Release - Demise of Shri Dwarika Prasad Tantia, Executive Chairman and Promoter | |
| 11.08.2025 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 11.08.2025 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 09.08.2025 | Transcript of the conference call on Un-Audited Financial Results for the 1st quarter ended on June 30, 2025 | |
| 07.08.2025 | Voting Results and Scrutinizer Report on 36th Annual General Meeting | |
| 07.08.2025 | Newspaper Publication of Q1FY26 Financial Results | |
| 07.08.2025 | Audio Recording of Q1 Earnings call held today i.e August 7, 2025 | |
| 06.08.2025 | Press Release for the Q1 ended June 30, 2025. | |
| 06.08.2025 | Submission of Results for the Q1 ended June 30, 2025. | |
| 06.08.2025 | Outcome of Board Meeting held on August 6, 2025. | |
| 06.08.2025 | Submission of Investors Presentation Q1 FY2026. | |
| 05.08.2025 | Outcome and Proceeding of the 36th Annual General Meeting of the Company. | |
| 28.07.2025 | Intimation of Earnings Call to discuss the financial performance of the Company for the 1st quarter ended June 30, 2025. | |
| 28.07.2025 | Intimation of Board Meeting pursuant to Regulations 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on August 6, 2025. | |
| 15.07.2025 | Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for Q.E June 30, 2025. | |
| 14.07.2025 | Newspaper Publication of Post Despatch of AGM Notice | |
| 12.07.2025 | Submission of Notice of 36th Annual General Meeting on Tuesday, August 5, 2025 | |
| 12.07.2025 | Submission of Annual Report including Notice of 36th AGM | |
| 12.07.2025 | Dispatch of Letter under Reg 36(1)(b) | |
| 07.07.2025 | Newspaper Publication of Pre Despatch of AGM Notice | |
| 27.06.2025 | Closure of Trading Window | |
| 26.05.2025 | Transcript of the conference call on Audited Financial Results for the 4th quarter and financial year ended March 31, 2025 | |
| 24.05.2025 | Filing of Secretarial Compliance Report for the year ended March 31, 2024 | |
| 24.05.2025 | Audio Recording of Q4FY2025 Earnings call held today i.e May 24, 2025 | |
| 24.05.2025 | Newspaper Publication of Q4FY25 Audited Financial Results | |
| 23.05.2025 | Outcome of Board Meeting held on May 23, 2025 | |
| 23.05.2025 | Submission of Results for the Q4 and Year ended March 31, 2025 | |
| 23.05.2025 | Press Release for the Q4 and Year ended March 31, 2025 | |
| 23.05.2025 | Submission of Investors Presentation Q4 FY2025 | |
| 23.05.2025 | Details of 36th Annual General Meeting, Book Closure Date and Record Date for Dividend | |
| 21.05.2025 | Intimation of earnings call for discussion on Audited Financial Results for the 4th quarter and financial year ended March 31, 2025 | |
| 14.05.2025 | Intimation of Board Meeting pursuant to Regulations 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on May 23, 2025. | |
| 11.05.2025 | Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 02.05.2025 | Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 18.04.2025 | Intimation under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 (“LODR Regulations”)-Change in the correspondence details of Registrar and Share Transfer Agent (RTA) of the Company | |
| 10.04.2025 | Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for Q.E March 31, 2025 | |
| 28.03.2025 | Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 27.03.2025 | Closure of Trading Window | |
| 21.03.2025 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 14.02.2025 | Update on Conference Call held on November 14, 2024 - Call Transcript | |
| 12.02.2025 | Audio Recording of Q3 Earnings call held today i.e February 12, 2025 | |
| 12.02.2025 | Newspaper Publication of Q3FY25 Financial Results | |
| 11.02.2025 | Outcome of Board Meeting held on February 11, 2025 | |
| 11.02.2025 | Submission of Un-Audited Financial Results for the Quarter ended December 31, 2024 | |
| 11.02.2025 | Integrated Filing (Financial) for the quarter and nine months ended December 31, 2024 | |
| 11.02.2025 | Investor Presentation for the quarter ended December 31, 2024 | |
| 11.02.2025 | Press Release on the Un-Audited Financial Results for the quarter ended December 31, 2024 | |
| 07.02.2025 | Intimation of Earnings Call to discuss the financial performance of the Company for the 3rd quarter ended on December 31, 2024 (Q3 & 9MFY25) | |
| 22.01.2025 | Intimation of Board Meeting pursuant to Regulations 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on February 11, 2025. | |
| 13.01.2025 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | |
| 03.01.2025 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 27.12.2024 | Closure of Trading Window | |
| 05.12.2024 | Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015-MOU | |
| 21.11.2024 | Update on Conference Call held on November 14, 2024 - Call Transcript | |
| 19.11.2024 | Update on Conference Call held on November 14, 2024 - Call Transcript | |
| 19.11.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 16.11.2024 | Newspaper Publication of Q2FY25 Financial Results | |
| 15.11.2024 | Audio Recording of Q2 Earnings call held today i.e November 15, 2024 | |
| 14.11.2024 | Press Release on the Un-Audited Financial Results for the quarter ended September 30, 2024 | |
| 14.11.2024 | Investor Presentation for the quarter ended September 30, 2024 | |
| 14.11.2024 | Outcome of Board Meeting held on November 14, 2024 | |
| 14.11.2024 | Submission of Un-Audited Financial Results for the Quarter ended September 30, 2024 | |
| 14.11.2024 | Declaration of First Interim Dividend and Notice of Record Date | |
| 06.11.2024 | Intimation of Earnings Call to discuss the financial performance of the Company for the 2nd quarter and half year ended September 30, 2024 (Q2FY25). | |
| 04.11.2024 | Intimation of Board Meeting pursuant to Regulations 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on November 14, 2024. | |
| 14.10.2024 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | |
| 27.09.2024 | Closure of Trading Window | |
| 29.08.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 22.08.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 16.08.2024 | Update on Conference Call held on August 14, 2024 – Call Transcript | |
| 14.08.2024 | Audio Recording of Q1 Earnings call held today i.e August 14, 2024 | |
| 14.08.2024 | Newspaper Publication of Q1FY25 Financial Results | |
| 13.08.2024 | Outcome of Board Meeting held on August 13, 2024 | |
| 13.08.2024 | Submission of Un-Audited Financial Results for the Quarter ended June 30, 2024 | |
| 13.08.2024 | Investor Presentation for the quarter ended June 30, 2024 | |
| 13.08.2024 | Press Release on the Un-Audited Financial Results for the quarter ended June 30, 2024 | |
| 07.08.2024 | Intimation of Earnings Call to discuss the financial performance of the Company for the 1st quarter ended June 30, 2024 (Q1FY25). | |
| 07.08.2024 | Intimation of Board Meeting pursuant to Regulations 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on August 13, 2024. | |
| 26.07.2024 | Voting Results and Scrutinizer Report on 35th Annual General Meeting | |
| 25.07.2024 | Outcome and Proceeding of the 35th Annual General Meeting of the Company. | |
| 15.07.2024 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | |
| 04.07.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 02.07.2024 | Newspaper Publication of Post Despatch of AGM Notice | |
| 01.07.2024 | Submission of Notice of Annual General Meeting on Thursday, July 25, 2024 | |
| 01.07.2024 | Submission of Annual Report including Notice of 35th AGM | |
| 26.06.2024 | Closure of Trading Window | |
| 25.06.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 25.06.2024 | Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Execution of Agreements | |
| 25.06.2024 | Newspaper Publication of Pre Despatch of AGM Notice | |
| 20.06.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 14.06.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 29.05.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 29.05.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 27.05.2024 | Update on Conference Call held on May 22, 2024– Call Transcript | |
| 23.05.2024 | Newspaper Publication of Q4FY24 Financial Results | |
| 23.05.2024 | Filing of Secretarial Compliance Report for the year ended March 31, 2024 | |
| 22.05.2024 | Audio Recording of Q4 Earnings call held today i.e May 22, 2024 | |
| 21.05.2024 | Change in Directorate | |
| 21.05.2024 | Statement Of Deviation For The Quarter Ended March 31, 2024 | |
| 21.05.2024 | Outcome of Board Meeting held on May 21, 2024 | |
| 21.05.2024 | Submission of Results for the Q4 and Year ended March 31, 2024 | |
| 21.05.2024 | Press Release for the Q4 and Year ended March 31, 2024 | |
| 21.05.2024 | Submission of Investors Presentation Q4 FY2024 | |
| 21.05.2024 | Details of 35th Annual General Meeting, Book Closure Date and Record Date for Dividend | |
| 14.05.2024 | Intimation of Earnings Call to discuss the financial performance of the Company for the 4th quarter and year ended March 31, 2024. | |
| 14.05.2024 | Intimation of Board Meeting pursuant to Regulations 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on May 21, 2024 | |
| 10.05.2024 | Disclosure of Postal Ballot Results along with Scrutinizer Report | |
| 09.05.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 26.04.2024 | Intimation regarding change of Corporate Identification Number ("CIN") of GPT Healthcare Limited ("The Company") | |
| 25.04.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 25.04.2024 | Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Execution of Lease Agreement | |
| 24.04.2024 | Compliance Certificate under reg 7(3) of the SEBI (LODR) Regulations, 2015 for the year ended March 31, 2024 | |
| 24.04.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 20.04.2024 | Resignation of Dr. Bharbi Chattopadhayay, SMP | |
| 16.04.2024 | Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for Q.E March 31, 2024 | |
| 16.04.2024 | Certificate pursuant to Regulation 40(9) & (10) of the SEBI (LODR), Regulations, 2015 for the Q.E March 31, 2024 | |
| 16.04.2024 | Fund raising by issuance of debt securities by Large Entities | |
| 12.04.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 09.04.2024 | Newspaper Publication of Postal Ballot Notice | |
| 08.04.2024 | Notice of Postal Ballot | |
| 28.03.2024 | Closure of Trading Window | |
| 23.03.2024 | Transcript of Conference Call held on Thursday, March 21, 2024. | |
| 21.03.2024 | Revision of Outcome of Board Meeting held on March 19, 2024 | |
| 21.03.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 21.03.2024 | Audio Recording of Q3 Earnings call held today i.e March 21, 2024 | |
| 20.03.2024 | Newspaper Publication of Q3 Financial Results and Notice of Record Date | |
| 19.03.2024 | Revised Notice of Record Date | |
| 19.03.2024 | Submission of Investors Presentation Q3FY24 | |
| 19.03.2024 | Intimation in terms of Regulation 30(5) of the SEBI (Listing Obligations and DisclosureRequirements) Regulations, 2015. | |
| 19.03.2024 | Press Release on Q3 FY 2024 Financial Results | |
| 19.03.2024 | Declaration of Second Interim Dividend and Notice of Record Date | |
| 19.03.2024 | Submission of Un-AuditedFinancial Results for theQuarter and Nine Months ended December 31, 2023 | |
| 19.03.2024 | Outcome of Board Meeting held on March 19, 2024. | |
| 18.03.2024 | Intimation of Earnings Call to discuss the financial performance of the Company for the 3rd quarter ended December 31, 2023 | |
| 17.03.2024 | Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. | |
| 12.03.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI(LODR), Regulations 2015 | |
| 11.03.2024 | Intimation of Board Meeting pursuant to Regulations 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on March 19, 2024. | |
| 02.03.2024 | Closure of Trading Window | |
Secretarial Compliance Report
| Date | Documents | Download |
|---|---|---|
| 31.03.2026 | Secretarial Compliance Report for the year ended March 31, 2026 | |
| 31.03.2025 | Secretarial Compliance Report for the year ended March 31, 2025 | |
| 31.03.2024 | Secretarial Compliance Report for the year ended March 31, 2024 | |
Annual Return
| Documents | Download |
|---|---|
| MGT-7 (Annual Return)- 2025-26 | |
| MGT-7 (Annual Return)- 2024-25 | |
| MGT-7 (Annual Return)- 2023-24 | |
| MGT-7 (Annual Return)- 2022-23 | |
| MGT-7 (Annual Return)- 2021-22 | |
| MGT-7 (Annual Return)- 2020-21 | |
Code of Conduct
| Documents | Download |
|---|---|
| Code of Conduct | |
Reports on Corporate Governance
| Financial Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2024-25 | | | | NA |
| 2023-24 | NA | NA | NA | |
Credit Rating
The long term and short term credit facilities are rated by CRISIL and the present rating of the Company is CRISIL A-/Stable (Reaffirmed)-Long Term Rating and CRISIL A2+ (Reaffirmed)-Short Term Rating on October 28, 2025.
Committees of the Board
Audit Committee
| Sl No. | Name | Position | Category |
|---|---|---|---|
| 1 | Mr. Deepak Pramanik | Chairman | Non-Executive - Independent Director |
| 2 | Mr. Kashi Prasad Khandelwal | Member | Non-Executive - Independent Director |
| 3 | Mr. Amrendra Prasad Verma | Member | Non-Executive - Independent Director |
Stakeholders Relationship Committee
| Sl No. | Name | Position | Category |
|---|---|---|---|
| 1 | Mr. Hari Modi | Chairman | Non-Executive Independent Director |
| 2 | Dr. Tapti Sen | Member | Non-Executive Independent Director |
| 3 | Mr. Anurag Tantia | Member | Whole-time Director |
Corporate Social Responsibility Committee
| Sl No. | Name | Position | Category |
|---|---|---|---|
| 1 | Dr. Om Tantia | Chairman | Chairman and Managing Director |
| 2 | Dr. Aruna Tantia | Member | Non-Executive – Non-Independent Director |
| 3 | Dr. Tapti Sen | Member | Non-Executive – Independent Director |
Nomination and Remuneration Committee
| Sl No. | Name | Position | Category |
|---|---|---|---|
| 1 | Mr. Kashi Prasad Khandelwal | Chairman | Non-Executive – Independent Director |
| 2 | Dr. Tapti Sen | Member | Non-Executive – Independent Director |
| 3 | Mr. Hari Modi | Member | Non-Executive – Independent Director |
Board of Directors
Dr. Om Tantia
Designation: Chairman & Managing Director (KMP)
Mr. Shree Gopal Tantia
Designation: Vice Chairman
Dr. Aruna Tantia
Designation: Non-Executive Director
Dr. Ghanshyam Goyal
Designation: Non-Executive Director
Mr. Anurag Tantia
Designation: Executive Director (KMP)
Mr. Kashi Prasad Khandelwal
Designation: Independent Director
Mr. Amrendra Prasad Verma
Designation: Independent Director
Mr. Deepak Pramanik
Designation: Independent Director
Dr. Tapti Sen
Designation: Independent Director
Mr. Hari Modi
Designation: Independent Director
Stock Information
Saksham Niveshak
| Sl. No. | Document | Download |
|---|---|---|
| 1 | Newspaper Advertisement by Company | |
| 2 | Circular issued by the Investor Education and Protection Fund Authority (“IEPFA”), Ministry of Corporate Affairs (“MCA”), dated July 16, 2025 | |
| 3 | Letter / Communication under 100 days Campaign - “Saksham Niveshak for creating awareness among shareholders by the Company | |
| 4 | Circular issued by the Investor Education and Protection Fund Authority (“IEPFA”), Ministry of Corporate Affairs (“MCA”), dated March 27, 2026 | |
| 5 | Newspaper Advertisement by Company-Second 100 Days Campaign | |
| 6 | Intimation regarding Second 100 days campaign-"Saksham Niveshak". | |
Listing Information
"The equity shares of GPT Healthcare Limted is listed on National Stock
Exchange of India Limited and BSE Limited. w.e.f. February 29, 2024"
National Stock Exchange (NSE)
Exchange Plaza, C-1, Block G Bandra Kurla Complex Bandra (E)
Mumbai 400 051
The Bombay Stock Exchange Limited (BSE)
Phiroze Jeejeebhoy Towers Dalal Street
Mumbai 400 001
| Stock Code | |
|---|---|
| BSE Scrip Code | 544131 |
| NSE Scrip Code | GPTHEALTH |
Changes in the company name
Our Company was originally incorporated as "Jibansatya Printing House Private Limited", a private limited company under the Companies Act, 1956 on August 17, 1989 at Kolkata, West Bengal. The name of our Company was subsequently changed to "GPT Healthcare Private Limited" on March 31, 2005. Thereafter, our Company was converted to a public limited company and our name was changed to "GPT Healthcare Limited on September 15, 2021.
Online Dispute Resolution (ODR)
| Title | Action |
|---|---|
| Sebi Circular SEBI/HO/OIAE/OIAE_IAD-1/P/CIR/2023/131 dated July 31, 2023 | |
| Sebi Circular SEBI/HO/OIAE/OIAE_IAD-1/P/CIR/2023/135 dated August 04, 2023 | |
| Sebi Circular SEBI/HO/OIAE/IGRD/CIR/P/2023/156 dated September 20, 2023 | |
| Process Flow of Complaints Redressal System | |
| Link to Smart ODR Platform | Link to ODR Portal |
Financials
Quarterly Results
| 2026 - 2027 | Q 1 | Q 2 | Q 3 | Q 4 |
|---|---|---|---|---|
| Standalone |  | | NA | NA |
| 2025 - 2026 | Q 1 | Q 2 | Q 3 | Q 4 |
|---|---|---|---|---|
| Standalone | | | | |
| 2024 - 2025 | Q 1 | Q 2 | Q 3 | Q 4 |
|---|---|---|---|---|
| Standalone | | | | |
| 2023 - 2024 | Q 1 | Q 2 | Q 3 | Q 4 |
|---|---|---|---|---|
| Standalone | NA | NA | | |
Annual Reports
CSR
Details of CSR amount spent on CSR Projects/Programmes duly approved by the Board
| Financial Year | Documents |
|---|---|
| 2025-26 | |
| 2024-25 | |
Downloads
| Form | Download-Form(pdf) | Fillable-Form | Purpose |
|---|---|---|---|
| Form ISR-1 | Request Form for Registering | Registering Request Fillable-ISR-1 | Request for Registering PAN, KYC details OR Changes/updations there of (only for securities held in physical) |
| Form ISR-2 | Bank Verification for Sign | Bank Verification Fillable-ISR-2 | Confirmation of Signature of securities holder by Banker |
| Form ISR-3 | ISR-3 Opt Out | Declaration Form for Opting-out of Nomination Fillable-ISR-3 | Declaration for Opting-out of Nomination by holders of physical securities in Listed Companies |
| Form SH-13 | SH-13 Registration of Nominationn | Fillable-SH-13 | Nomination Form |
| Form SH-14 | Cancellation OR Variation of Nomination | Fillable-SH-14 | Cancellation OR Variation of Nomination |
Annexures/Forms for declaration by shareholders for ascertaining TDS applicability on Dividends
| Annexures/Forms | Download- Annexures/Forms (PDF) |
|---|---|
| Annexure 1 - Form No. 121 | |
| Annexure 2 - Self Declaration (Resident Shareholder) | |
| Annexure 3 - Self Declaration regarding credit for tax deducted at source | |
| Annexure 4 - Form No. 41 | |
| Annexure 5 - Declaration that income is assessable in hands of other person | |
Contact
Investor Relations/
Grievance Redressal/
Nodal Officer for IEPF
Company Secretary & Compliance Officer
GPT Healthcare Limited
Mr. Ankur Sharma
GPT Centre, JC-25, Sector-III
Salt Lake, Kolkata - 700 106
+91 33 4050 7000
ghl.cosec@gptgroup.co.in
Registrar & Share Transfer Agent
Mumbai
MUFG Intime India Private Limited
(Formerly Link Intime India Pvt. Ltd.)
C-101, 247 Park,
LBS MARG, Vikhroli (West)
Mumbai - 400083
+91 22 49186200
gpthealthcare.ipo@linkintime.co.in
rnt.helpdesk@in.mpms.mufg.com
Kolkata
MUFG Intime India Private Limited
(Formerly Link Intime India Pvt. Ltd.)
Rasoi Court, 5th floor
20, Sir R N Mukherjee Road,
Kolkata - 700001
033-6906 6200
kolkata@in.mpms.mufg.com
Note: All shareholder queries or service requests in electronic mode are to be raised only through RTA website, the link for which is https://web.in.mpms.mufg.com/helpdesk/Service_Request.html